STATE OF WISCONSIN INVESTMENT BOARD - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,625,863
-49.5%
11,133
-20.1%
0.01%
-44.4%
Q2 2023$3,218,061
+14.2%
13,931
+19.7%
0.01%
+12.5%
Q1 2023$2,818,937
-15.5%
11,636
+1.3%
0.01%
-27.3%
Q4 2022$3,335,553
+319.6%
11,492
-6.0%
0.01%
+266.7%
Q3 2022$795,000
-3.8%
12,231
+6.0%
0.00%
+50.0%
Q2 2022$826,000
-43.1%
11,534
-22.1%
0.00%
-33.3%
Q1 2022$1,452,000
+15.8%
14,8000.0%0.00%
+50.0%
Q4 2021$1,254,000
+6.2%
14,8000.0%0.00%0.0%
Q3 2021$1,181,000
+3.6%
14,800
+26.5%
0.00%0.0%
Q2 2021$1,140,000
-16.7%
11,7000.0%0.00%
-33.3%
Q1 2021$1,369,000
-1.5%
11,700
-6.4%
0.00%0.0%
Q4 2020$1,390,000
-16.4%
12,500
-10.7%
0.00%
-25.0%
Q3 2020$1,662,000
-1.5%
14,000
-6.0%
0.00%
-20.0%
Q2 2020$1,687,000
+65.2%
14,900
-2.6%
0.01%
+66.7%
Q1 2020$1,021,000
-60.8%
15,300
-46.4%
0.00%
-57.1%
Q4 2019$2,602,000
+157.9%
28,561
+144.1%
0.01%
+133.3%
Q3 2019$1,009,000
-5.6%
11,700
+14.7%
0.00%0.0%
Q2 2019$1,069,000
-14.7%
10,200
+2.0%
0.00%
-25.0%
Q1 2019$1,253,000
+54.3%
10,000
+38.9%
0.00%
+33.3%
Q4 2018$812,000
-46.6%
7,200
+1.4%
0.00%
-25.0%
Q3 2018$1,520,000
-9.4%
7,100
+18.3%
0.00%
-20.0%
Q2 2018$1,678,000
+379.4%
6,000
+100.0%
0.01%
+400.0%
Q1 2018$350,000
+27.3%
3,0000.0%0.00%0.0%
Q4 2017$275,0003,0000.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$5,047,0003.31%
L1 Capital Pty Ltd 161,163$10,474,0002.05%
Avoro Capital Advisors LLC 1,535,000$99,760,0001.84%
Affinity Asset Advisors, LLC 100,000$6,499,0001.81%
GREAT POINT PARTNERS LLC 95,500$6,207,0001.50%
ARMISTICE CAPITAL, LLC 1,236,000$80,328,0001.39%
Affinity Asset Advisors, LLC 75,000$4,874,0001.36%
MPM BioImpact LLC 44,747$2,908,0000.69%
Baker Brothers Advisors 1,499,213$97,434,0000.64%
Perceptive Advisors 331,023$21,513,0000.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders